Cargando…

Return to work after cell transplantation in patients with angiitis-induced critical limb ischaemia and factors related: a single-centre retrospective cohort study

BACKGROUND: Angiitis-induced critical limb ischaemia (AICLI) patients, who are usually young and have a high amputation rate, always lose their ability to return to the labour force. Return to work (RTW) not only indicates patients’ physical health, showing that they could undertake the work, but al...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hao, Liu, Yifan, Pan, Tianyue, Fang, Yuan, Fang, Gang, Jiang, Xiaolang, Chen, Bin, Wei, Zheng, Gu, Shiyang, Liu, Peng, Fu, Weiguo, Dong, Zhihui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972707/ https://www.ncbi.nlm.nih.gov/pubmed/35365238 http://dx.doi.org/10.1186/s13287-022-02807-1

Ejemplares similares

Autologous Stem Cells Transplantation for No-Option Angiitis-Induced Critical Limb Ischemia: Recurrence and New Lesion
por: Liu, Hao, et al.
Publicado: (2022)

The peripheral blood mononuclear cells versus purified CD34(+) cells transplantation in patients with angiitis-induced critical limb ischemia trial: 5-year outcomes and return to work analysis—a randomized single-blinded non-inferiority trial
por: Liu, Hao, et al.
Publicado: (2022)

Long-Term Outcomes of Peripheral Blood Mononuclear Cells in the Treatment of Angiitis-Induced No-Option Critical Limb-Threatening Ischemia
por: Jiang, Xiaolang, et al.
Publicado: (2021)

Autologous peripheral blood-derived stem cells transplantation for treatment of no-option angiitis-induced critical limb ischemia: 10-year management experience
por: Fang, Gang, et al.
Publicado: (2020)

Three‐year outcomes of peripheral blood mononuclear cells vs purified CD34 (+) cells in the treatment of angiitis‐induced no‐option critical limb ischemia and a cost‐effectiveness assessment: A randomized single‐blinded noninferiority trial
por: Liu, Hao, et al.
Publicado: (2021)

Purified CD34(+) cells versus peripheral blood mononuclear cells in the treatment of angiitis-induced no-option critical limb ischaemia: 12-Month results of a prospective randomised single-blinded non-inferiority trial
por: Dong, Zhihui, et al.
Publicado: (2018)

A Five‐Year Study of the Efficacy of Purified CD34+ Cell Therapy for Angiitis‐Induced No‐Option Critical Limb Ischemia
por: Fang, Yuan, et al.
Publicado: (2018)

Prediction of 2-Year Major Adverse Limb Event-Free Survival After Percutaneous Transluminal Angioplasty and Stenting for Lower Limb Atherosclerosis Obliterans: A Machine Learning-Based Study
por: Pan, Tianyue, et al.
Publicado: (2022)

Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia
por: Pan, Tianyue, et al.
Publicado: (2019)

Surgical treatment in critical limb ischaemia
por: Roscitano, G, et al.
Publicado: (2010)

Upper limb ischaemia: a South African single–centre experience
por: du Toit, Tinus, et al.
Publicado: (2018)

THE PATHOLOGY OF LIMB ISCHAEMIA
Publicado: (1967)

Toll-Like Receptors in Ischaemia and Its Potential Role in the Pathophysiology of Muscle Damage in Critical Limb Ischaemia
por: Patel, Hemanshu, et al.
Publicado: (2012)

Cutaneous Angiitis
por: Copeman, P. W. M.
Publicado: (1975)

Takotsubo cardiomyopathy with left ventricular thrombus presenting as critical limb ischaemia
por: Gulsin, Gaurav, et al.
Publicado: (2016)

Thrombo-Angiitis Obliterans
por: Chakravarti, D. C.
Publicado: (1935)

Atypical Presentation of Critical Lower Limb Ischaemia Treated with Aortobifemoral Biosynthetic Prosthesis
por: Elsawi, Ali, et al.
Publicado: (2018)

Endovascular thrombectomy for critical lower limb ischaemia in a patient with COVID-19
por: Kumar, Subhash, et al.
Publicado: (2021)

Long‐Term Outcomes of Chronic Type B Aortic Dissection Treated by Thoracic Endovascular Aortic Repair
por: Jiang, Xiaolang, et al.
Publicado: (2022)

Microvascular Permeability and Texture Analysis of the Skeletal Muscle of Diabetic Rabbits With Critical Limb Ischaemia Based on DCE-MRI
por: Yang, Qi, et al.
Publicado: (2022)

Maggot debridement therapy for a patient with critical limb ischaemia and severe cardiac dysfunction: possibility of limb salvage
por: Nishijima, Akio, et al.
Publicado: (2017)

Critical limb ischaemia in a diabetic population from an Asian Centre: angiographic pattern of disease and 3-year limb salvage rate with percutaneous angioplasty as first line of treatment
por: Tan, M, et al.
Publicado: (2010)

Trans-iliac Bypass for Critical Limb Ischaemia with Groin Necrosis: A Case Report
por: Lounes, Youcef, et al.
Publicado: (2019)

Critical ischaemia of the hand and upper limb in a patient with long COVID-19 infection
por: Lees, Vivien C., et al.
Publicado: (2021)

COVID-19 Presenting as Acute Limb Ischaemia
por: Kaur, Parminder, et al.
Publicado: (2020)

Distal Limb Ischaemia in Association With Takotsubo Cardiomyopathy
por: Yeap, Keng Han, et al.
Publicado: (2023)

Single-Cell Sequencing of Immune Cells in Human Aortic Dissection Tissue Provides Insights Into Immune Cell Heterogeneity
por: Liu, Yifan, et al.
Publicado: (2022)

A Thermoresponsive Chitosan/β-Glycerophosphate Hydrogel for Minimally Invasive Treatment of Critical Limb Ischaemia
por: Herron, Caroline, et al.
Publicado: (2021)

A Case of Thrombo-Angiitis Obliterans
por: Pai, M. N.
Publicado: (1931)

Primary Idiopathic Frosted Branch Angiitis
por: Maleki, Shahin Jahani, et al.
Publicado: (2020)

Comparison between endovascular aneurysm repair-selected and endovascular aneurysm repair-only strategies for the management of ruptured abdominal aortic aneurysms: An 11-year experience at a Chinese tertiary hospital
por: Fang, Gang, et al.
Publicado: (2022)

Fetal Limb Ischaemia in Twin-to-Twin Transfusion Syndrome
por: Kilby, Mark, et al.
Publicado: (2013)

Acute Lower Limb Ischaemia in COVID19 Patients
por: Spinelli, D., et al.
Publicado: (2023)

Delays to revascularization for patients with chronic limb-threatening ischaemia
por: Li, Qiuju, et al.
Publicado: (2022)

Enhanced Vascular Endothelial Growth Factor Gene Expression in Ischaemic Skin of Critical Limb Ischaemia Patients
por: Bleda, Silvia, et al.
Publicado: (2012)

Systematic review of pharmacological therapies for the management of ischaemic pain in patients with non-reconstructable critical limb ischaemia
por: Laoire, Áine Ní, et al.
Publicado: (2018)

Impact of COVID-19 Pandemic on the Outcomes in Patients With Critical Limb Threatening Ischaemia and Diabetic Foot Infection
por: Zayed, Hany, et al.
Publicado: (2022)

Leg ischaemia management collaboration (LIMb): study protocol for a prospective cohort study at a single UK centre
por: Houghton, John S M, et al.
Publicado: (2019)

Management of Acute Limb Ischaemia Due to COVID-19 Induced Arterial Thrombosis: A Multi-Centre Indian Experience
por: Sekar, Natarajan, et al.
Publicado: (2022)

Bmal1 Downregulation Worsens Critical Limb Ischemia by Promoting Inflammation and Impairing Angiogenesis
por: Xu, Lirong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_0e9h9nfpc35p3nkq5fu0ukp2s5